Selectively Replicating Adenoviruses for Oncolytic Therapy
Journal:
Current Cancer Drug Targets
Volume:
1
Page:
85-107
Author(s):
Tack-Kee Laurent Yoon, Toshiaki Shichinohe, Sylvie Laquerre and Noriyuki Kasahara
Mutant Cell Surface Receptors as Targets for Individualized Cancer Diagnosis and Therapy
Journal:
Current Cancer Drug Targets
Volume:
1
Page:
121-128
Author(s):
Karl-Friedrich Becker and Heinz Hofler
Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
171-199
Author(s):
Zafar H. israili
Anthracyclines: Selected New Developments
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
1
Page:
113-130
Author(s):
M. Binaschi, M. Bigioni, A. Cipollone, C. Rossi, C. Goso, C. A. Maggi, G. Capranico and F. Animati
Targeting p53 in Cancer
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
1
Page:
151-161
Author(s):
Patrick Chene
Rate Limiting Steps of AAV Transduction and Implications for Human Gene Therapy
Journal:
Current Gene Therapy
Volume:
1
Page:
137-147
Author(s):
S. Sanlioglu, M. M. Monick, G. Luleci, G. W. Hunninghake and J. F. Engelhardt
Adenoviral Vector-Mediated Gene Transfer for Human Gene Therapy
Journal:
Current Gene Therapy
Volume:
1
Page:
149-162
Author(s):
Benjamin Breyer, Wei Jiang, Hongwei Cheng, Lan Zhou, Ronjon Paul, Tao Feng and Tong-Chuan He
Imaging Methods in Gene Therapy of Cancer
Journal:
Current Gene Therapy
Volume:
1
Page:
163-182
Author(s):
Uwe Haberkorn and Annette Altmann
Cell Cycle Checkpoint Genes and Aneuploidy: A Short Review
Journal:
Current Genomics
Volume:
2
Page:
171-180
Author(s):
William G. Kearns and Johnson M. Liu
Induction of CYP1A1. The AhR / DRE Paradigm Transcription, Receptor Regulation, and Expanding Biological Roles
Journal:
Current Drug Metabolism
Volume:
2
Page:
149-164
Author(s):
Qiang Ma